baber/WOPTO huggingface dataset:
Patent EP-1105196-A1 (EP)
Inventor: GOLAD ADAR
IPC: A63F3/04
Filed: 1999-08-20
Abstract: L'invention concerne un assemblage d'un premier nombre de palets sur un plateau, le plateau étant divisé en un second nombre de zones de jeu. Chaque palet est doté d'une surface supérieure et d'une surface inférieure s'étendant au moins presque parallèlement à la surface supérieure. Au moins l'une ou l'autre de ces surfaces est dotée d'un troisième nombre d'évidements agencés selon un motif déterminé. Un quatrième nombre d'évidements, non supérieur au troisième, loge un élément en forme de pastille. A proximité de chaque zone de jeu, des éléments de rétention saillant au-dessus du plateau de jeu sont présents, qui servent à loger entre eux, de manière amovible, les palets de jeu.
Patent EP-1220679-A1 (EP)
Title: Cell-based gene therapy for the pulmonary system
Inventor: STEWART DUNCAN J
IPC: A61K35/36
Filed: 1999-09-23
Abstract: Cell-based gene transfer is effected by administering transfected fibroblast cells, from dermal or other origins, containing an expressible transgene coding for an angiogenic factor or other therapeutic factor, into the pulmonary circulation of a patient, where the cells express and secrete expression products of the transgene to act locally at the site of expression, and in some cases to be conveyed by the patient's circulation to other body organs. The process is especially useful in treatment of pulmonary hypertension by means of expressed angiogenic factors.
Patent EP-1054730-A1 (EP)
Inventor: TSUSHIO YOSHINORI
IPC: B01J20/22
Filed: 1999-09-24
Abstract: L'objet de la présente invention est une composition facile à manipuler destinée au traitement par adsorption, un procédé pour préparer aisément cette composition sous forme de grains qui n'affecte pas ses capacités d'adsorption, des produits tels qu'un dispositif de traitement par adsorption et un filtre à air contenant cette composition et, enfin, un procédé de traitement par adsorption. La composition destinée au traitement par adsorption de cette invention comprend une substance adsorbante qui entre en réaction avec les composés à adsorber en présence de l'humidité, une substance absorbant l'eau et un liant, le pourcentage en poids dudit liant étant compris entre 1,3 et 8 par rapport à la substance absorbant l'eau.
Patent EP-1133748-A1 (EP)
Title: Display system comprising a chip card and a reader
Inventor: LIBERMAN GEORGES
IPC: G06K7/00
Filed: 1999-10-19
Abstract: The invention concerns a display system comprising a plurality of chip cards (1) and a chip card reader (9), each chip card (1) comprising a software and a body (2) produced in synthetic material and wherein is provided a communication interface, the reader (9) comprising a box (10) and a display screen capable of displaying different messages, the box (10) being provided with a slot (12) capable of receiving a chip card (1), a communication interface being arranged in the slot for providing an electric connection between the reader (9) and each chip card (1). The chip card (1) comprises a display part (4) capable of being urged to co-operate by being superposed with the reader (9) display screen.
Patent EP-1044213-A1 (EP)
Inventor: DIETZ-BAND JEANNE
IPC: C12Q1/6841
Filed: 1999-10-13
Abstract: L'invention concerne un procédé de détection de translocations de gènes réciproques au moyen d'ensembles sondes multiples couvrant les régions de cassure et entourant les régions de chaque côté de la cassure de translocation, sur chaque chromosome affecté par la translocation. L'invention porte également sur des ensembles sondes et des kits de diagnostic.
Patent EP-1128838-A1 (EP)
Inventor: HEIDARAN MOHAMMAD A
IPC: A61K38/39
Filed: 1999-10-14
Abstract: L'invention concerne un procédé et une composition servant à déclencher ou à renforcer la chondrogenèse in vivo ou in vitro. Le procédé comporte l'étape consistant à exposer les cellules in vitro ou in vivo à une matrice extracellulaire constituée de collagène de type I, de collagène de type II ou d'un mélange de collagène de type I ou de type II et d'hyaluronate, et contenant en outre GDF-5.
Patent EP-1085871-A1 (EP)
Inventor: MACOR JOHN E
IPC: A61K31/505
Filed: 1999-06-02
Abstract: Nouveaux composés quinazolinone, procédés d'utilisation desdits composés dans le traitement d'états pathologiques associés à l'acide guanosine-3'5'-monosphosphate cyclique (cGMP), tels que les troubles de l'érection, et compositions pharmaceutiques contenant lesdits composés.
Patent EP-1123048-A1 (EP)
Inventor: MEHTA ROOMA
IPC: D02G3/02
Filed: 1999-10-16
Abstract: Synthetic absorbable medical devices made totally or in part from a random polymer comprising glycolide, lactide, trimethylene carbonate, and carpo-lactone, are provided. The polymer can be fabricated into monofilament (16) which exhibits physical characteristics equivalent to or superior than gut sutures.
Patent EP-1178093-A1 (EP)
Inventor: TANAKA SHOICHI
IPC: C09D161/20
Filed: 1999-12-20
Abstract: The present invention relates to a coating composition
containing 8 to 130 parts by weight of (B) silica fine
particles having an oil absorption in the range of 30 to 200
ml/100 g and a pore volume in the range of 0.05 to 1.2 ml/g
per 100 parts by weight of (A) a coating film-forming resin,
a cured coating film formed from the coating composition
having a glass transition temperature in the range of 40 to
125°C; and a coated metal plate having a coating film formed
from the above coating composition on the surface of a metal
plate.
Patent EP-1145321-A1 (EP)
Inventor: GOLKE KEITH W
IPC: H01L21/8234
Filed: 1999-12-07
Abstract: L'invention concerne un dispositif multifonction pouvant servir de résistance, de transistor MOSFET ou de transistor JFET. On forme la résistance en choisissant une première configuration d'interconnexion métallique, le transistor MOSFET en choisissant une deuxième configuration d'interconnexion, et le transistor JFET en choisissant une troisième configuration d'interconnexion métallique. Du fait de la nature double transistor/résistance dudit dispositif, on peut augmenter la densité d'une matrice de portes classique dans laquelle des résistances sont utilisées. Par ailleurs, et parce qu'aucun traitement n'est généralement requis, on peut utiliser ledit dispositif dans d'autres types de structures, telles que des cellules standard et une logique personnalisée.
Patent EP-1114052-A1 (EP)
Inventor: CALDERWOOD DAVID
IPC: A61P15/00
Filed: 1999-09-17
Abstract: Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases whose activity is inhibited by these compounds are involved in immunologic, hyperproliferative or angiogenic processes. Thus, these compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferative is a factor. These compounds can be used to treat cancer, hyperproliferation disorders, rheumatoid arthritis, disorders of the immune system, transplant rejection, and inflammatory disorders.
Patent FI-20185840-A1 (FI)
Inventor: LILJA JUHA
IPC: H04B7/145
Filed: 2018-01-11
Abstract: Den föreliggande uppfinningen avser ett byggnadsmaterial (110) som omfattar minst en elledande lågemissivitetsyta (103) som är försedd med en öppning (203) för att intensifiera transmission av en elektromagnetisk signal genom ett byggnadsmaterial, och varvid öppningen har en väsentligen mindre elledningsförmåga än lågemissivitetsytan (103). Kanten av sagda i lågemissivitetsytan (103) anordnade öppning (203) bildar minst en sluten kantkurva (223), och sagda öppning (203) definierar en sluten enveloppkurva (224) så att sagda öppning (203) ligger innanför den slutna enveloppkurvan (224), och varvid området som begränsas av den slutna enveloppkurvan (224) har en yta väsentligen större än ytan av öppningen (203) innanför den slutna enveloppkurvan (224), och en längd väsentligen mindre än längden av den slutna kantkurvan (223), varvid minst ett område (231) av lågemissivitetsytan (103) bildats innanför området som begränsas av den slutna enveloppkurvan (224), vid vilket den slutna enveloppkurvan (224) inte sammanfaller med kantkurvan (223). Sagda elledande område (231) på lågemissivitetsytan (103) definierar minst två kanter av öppningen (203), vilka är anordnade på minst ett avstånd (234), och varvid sagda kanter är minst delvis omlott.
Patent FI-20196131-A1 (FI)
Title: Dispersion of cellulose fibers and method of producing the same
Inventor: HAURU LAURI
IPC: D21H21/08
Filed: 2019-12-23
Abstract: A dispersion of cellulose fibers, a method of preparing the same and uses thereof. The dispersion is produced by providing a cellulose feedstock comprising cellulose fibers; by providing a mixture of an ionic liquid and a protic antisolvent for cellulose as a dispersion medium, the ionic liquid being selected from the group of protic salts of superbases capable of dissolving cellulose; and by mixing said cellulose feedstock into said dispersion medium so as to disperse the cellulose fibers therein to form a dispersion which is stable for at least 24 hours at room temperature. The dispersion can be used as an additive of cellulose pulps for making of fibrous products.
Patent FI-20196138-A1 (FI)
Inventor: RAASSINA SEPPO
IPC: B29C45/76
Filed: 2019-12-30
Abstract: Uppfinningen avser ett förfarande för kontroll av verkningar orsakade av värmeutvidgning hos komponenter i en formsprutningsform, där en kraftverkan mellan komponenterna orsakad av i formen uppvärmningbara eller nedkylbara komponenters värmeutvidgning mäts med åtminstone en kraftgivare och det mätbara kraftvärdet hålls inom ett önskat variationsintervall med hjälp av i anslutning till komponenterna installerat eller installerade manövreringsorgan som kompenserar för kraftverkningar orsakade av temperaturförändringar. Uppfinningen avser dessutom en formsprutningsform för plastprodukter.
Patent FI-20216175-A1 (FI)
Title: Epoxidation of olefin mixture
Inventor: RAUTIAINEN SARI
IPC: C07D303/04
Filed: 2021-11-16
Abstract: The present disclosure relates to a process for epoxidizing an olefin mixture, comprising at least two olefins selected from the group consisting of ethylene, propylene and 1-butylene. Particularly the present disclosure relates to a process comprising contacting the olefin mixture (11) and solvent with hydrogen peroxide (12) in the presence of a heterogeneous Lewis acid catalyst in a reactor (13); and recovering a product mixture (15) corresponding to the provided olefin mixture (11). The present disclosure further concerns the product obtained by the method as well as the use of the recovered product mixture in the production of polycarbonates, cyclic carbonates and/or polyols, preferably polycarbonate or polyether polyols for use in polyurethane products. The present disclosure also relates to an integrated process for producing epoxides, wherein the olefin mixture (11) is separated from Fischer-Tropsch synthesis (7).
Patent FI-20226089-A1 (FI)
Title: An apparatus for producing information indicative of cardiac abnormality
Inventor: BLOMSTER JUUSO
IPC: A61B5/11
Filed: 2022-12-09
Abstract: An apparatus for producing information indicative of a heart failure with reduced ejection fraction HFrEF comprises a signal interface (101) for receiving a signal indicative of cardiac angular rotations and a processing system (102) coupled to the signal interface. The processing system is configured to extract, from the signal, temporal portions which belongs to diastolic phases of a heart. The processing system is configured to set an output signal of the apparatus to express presence of a heart failure with reduced ejection fraction based on a result of a comparison between the indicator quantity and a threshold value.
Patent HK-1022692-A1 (HK)
Title: Inhibitors of tumor necrosis factor alpha
Inventor: MULLER GEORGE W
IPC: A61K31/40
Filed: 2000-03-20
Abstract: Novel nitriles are inhibitors of tumor necrosis factor  alpha  and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is 3-Phthalimido-3-(3,4-dimcthoxyphenyl)propionitrile.
Patent HK-1034943-A1 (HK)
Title: Ultrasonic sealing apparatus.
Inventor: KUME SATOSHI
IPC: B29C65/08
Filed: 2001-08-15
Abstract: To provide an ultrasonic sealing apparatus with an excellent sealability capable of: positively discharging contaminants such as juice pulp from sealing zones together with molten thermoplastic resin; and preventing a formation of the undulated molten resin beads by controlling the thickness and the width of the molten resin that flows out to the side in contact with a fluid. In an apparatus wherein a packing material consisting of a laminated body (1) comprising the thermoplastic resin layers is made into a tubular form and the tubular packing material is transverse-ultrasonically sealed with a fluid, a horn (12) with an elongated and flat sealing face, and grooves which can form the molten thermoplastic resin bulges in the vicinal area of the side of the sealing zones on the action face of the opposing jaw in contact with a fluid pressing the packing material in cooperation with the sealing face of the said horn, are disposed. Further, disposing grooves which can form the molten resin bulges in the vicinal area of the cutting side of sealing zones or an incline to allow the molten resin to flow out of sealing zones to the cutting side on the action face of the opposing jaw, is desirable. <IMAGE>
Patent HK-1046624-A1 (HK)
Title: Machine for preassembling and assembling an upper on a shoe-making last
Inventor: CARLO BIANCHI
IPC: A43D23/02
Filed: 2002-11-12
Abstract: A machine (1) for the preassembly and assembly of an upper (2) on a shoe-making last (3) comprises a bearing structure (9) with which are associated: a support (4) on which to position last (3) along a longitudinal axis (L-L), a central gripper (5) positioned in alignment with the front part of the last (3) and first and second opposing pluralities of lateral grippers (10, 11). Wherein the lateral grippers (10, 11) are associated with a respective support member (13, 14), movable relative to the bearing structure (9) on a curved trajectory (T) encompassing said support means (4). Advantageously, the support members (13, 14) are mounted on respective trolleys (20, 21) which can move from and to a remote position in which the respective pluralities of lateral grippers (10, 11) are at a distance from the central gripper (5), so as to create a sufficient space to manipulate a tool around the central gripper (5).   <IMAGE>
Patent HK-1054911-A1 (HK)
Title: Methods of synthesizing an oxidant and applications thereof
Inventor: EDWARD CIAMPI LEE
IPC: C02F1/52
Filed: 2003-10-14
Abstract: Novel methods and devices for synthesizing ferrate and uses thereof are described. One aspect of the invention relates to synthesizing ferrate at a site proximal to the site of use, another aspect of the invention relates to devices and methods for synthesizing ferrate.
Patent HK-1058043-A1 (HK)
Title: Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21- dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation ;
Inventor: SCHMIDT BEATE
IPC: C07B61/00
Filed: 2004-02-09
Abstract: The invention relates to a process for the preparation of 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione[11beta,16alpha(R)] and similar compounds, by reaction of an appropriate 16,17-ketal with cyclohexanealdehyde.
Patent HK-1073452-A1 (HK)
Title: Child-resistant blister pack
Inventor: FRENCH GARY STUART
IPC: B65D75/34
Filed: 2005-05-17
Abstract: The child-resistant blister pack for unit dosage forms has a blister film sheet with depressions therein, unit dosage forms within the depressions and a lidding sheet which overlies the depressions and which is secured to the film sheet so as to seal the unit dosage forms within the depressions. A network of lines of weakness in the pack define a plurality of dosage units. Each dosage unit includes one of said dosage forms and a peel region where part of the lidding sheet is not secured to the blister film sheet. Each peel region is disposed adjacent a respective one of the lines of weakness. The lines of weakness include (a) a first line of weakness extending from a first access point so that, when the first access point is exposed, the blister film sheet and the lidding sheet can be torn along the first line of weakness to expose a second access point and to enable access to the peel region of the first dosage unit; (b) a second line of weakness extending from the second access point so that, when the second access point is exposed, the blister film sheet and the lidding sheet can be torn along the second line of weakness to expose a third access point and enable access to the peel region of the second dosage unit; and (c) a third line of weakness which is spaced from the first line of weakness and which extends from the third access point so that, when the third access point is exposed, the blister film sheet and the lidding sheet can be torn along the third line of weakness to enable access to the peel region of a third dosage unit.
Patent HK-1085230-A1 (HK)
Title: Composition for the protection of a shaped articleagainst corrosion
Inventor: NOOREN FRANS
IPC: C08K3/00
Filed: 2006-07-04
Abstract: The invention relates to a composition for the protection of a shaped article against corrosion, said composition comprising (a) a polyisobutene having a glass transition temperature of less than −20° C. and surface tension of less than 40 mM/m at a temperature above the glass transition temperature of said polyisobutene, (b) a filler material and (c) an anti-oxidant composition. The anti-oxidant composition comprises a primary and/or a secondary anti-oxidant, the primary anti-oxidant being selected from the group consisting of sterically hindered phenol compounds. The invention further relates to a wrapping tape comprising said composition for the protection of a shaped article, a process for the manufacture of said wrapping tape and a process for covering a shaped article with said wrapping tape.
Patent HK-1087745-A1 (HK)
Title: Noise prevention wall system comprising a base and a transparent top part
Inventor: WIEBEL WOLFFGANG
IPC: E01F8/00
Filed: 2006-07-14
Abstract: A noise barrier system composed of a base and a transparent superstructure. A support holds at least two adjacent transparent noise barrier elements and includes a point-fastening of the transparent noise barrier element. A position of upper holding points of the transparent superstructure is arranged at a height of from 70 to 90% of a total height of the transparent noise barrier element and at a distance of from 3 to 50 times a thickness of the transparent noise barrier element from a vertical edge. An upper side of the transparent noise barrier element has a flexure, an angle of the flexure being from 30° to 90° from vertical, and a width of an angled region being from 5 cm to 50 cm, and an entire length of a lower side of the sheet is secured within a groove-shaped depression.
Patent HK-1092696-A1 (HK)
Title: Novel use of a polyamine-poor composition for the production of a medical human food
Inventor: MOULINOUX JACQUES-PHILIPPE
IPC: A23L1/305
Filed: 2006-10-26
Abstract: The use of a human food composition (A) containing less than 1600 picomoles per g of polyamines (I) is claimed in the production of a therapeutic food for combating syndromes or disorders involving the NR2-N subunit of the N-methyl-D-aspartate (NMDA) receptor. ACTIVITY : Analgesic; Vasotropic; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Virucide; Antimanic; Antidepressant; Neuroleptic; Antiaddictive; Auditory. In tests in rats fed (a) a solid diet with a very low polyamine (I) content of less than 10 mu g/kg or (b) the same diet supplemented with the polyamines putrescine (54 mg/kg), spermine (7 mg/kg) and spermidine (7 mg/kg) (i.e. the levels present in normal rodent feed), the sensitivity to pain caused by two injections (7 days apart) of carrageenan into the paw was measured by the Randall-Selitto test. The level of pain in the days following the second injection was markedly lower in group (a) than that in group (b), demonstrating that the low-(I) diet in group (a) reduced the sensitivity to pain. The levels of pain in the days following the first injection were not significantly different, demonstrating the low-(I) diet had no direct analgesic effect. MECHANISM OF ACTION : NMDA receptor NR2-N subunit modulator.
Patent HK-1106773-A1 (HK)
Title: Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
Inventor: RUECKLE THOMAS T
IPC: C07D/
Filed: 2008-01-16
Abstract: The present invention is related to pyridine methylene azolidinone derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
Patent HK-1107043-A1 (HK)
Title: Oral compositions for prevention and reduction of bacterial adhesion to oral surfaces
Inventor: TRIVEDI HARSH M
IPC: A61K/
Filed: 2008-01-22
Abstract: The present invention encompasses an oral composition containing an anti-adhesion agent, preferably a cysteine protease and most preferably ficin. In another aspect, the cysteine protease is in combination with one or more ingredients, such as antibacterial agent and surfactant. The anti-adhesion agent mitigates interaction between a subject oral cavity and plaque-forming materials.
Patent HK-1126274-A1 (HK)
Title: T cell assays t
Inventor: BAKER MATHEW
IPC: G01N/
Filed: 2009-05-11
Abstract: The present invention relates to novel T cell assay methods, in particular where T cell responses to test antigens are increased by removal of regulatory T cells. Novel assays where the timing of incubation with antigens or other samples is varied in order to optimize detection of T cell responses are described. The invention has particular application for measurement of human T cell responses to pharmaceuticals, allergens, irritants or other substances.
Patent HK-1136906-A1 (HK)
Title: Controlling inductive power transfer systems
Inventor: STEVENS MICHAEL CRAIG
IPC: H02M/
Filed: 2010-01-18
Abstract: An inductive power transfer system (1) comprises a primary unit (10) operable to generate an electromagnetic field and at least one secondary device (30), separable from the primary unit, and adapted to couple with the field when the secondary device is in proximity to the primary unit so that power can be received inductively by the secondary device from the primary unit without direct electrical conductive contacts therebetween. The system detects if there is a substantial difference between, on the one hand, a power drawn from the primary unit and, on the other hand, a power required by the secondary device or, if there is more than one secondary device, a combined power required by the secondary devices. Following such detection, the system restricts or stops the inductive power supply from the primary unit.  Such a system can detect the presence of unwanted parasitic loads in the vicinity of the primary unit reliably.
Patent HK-1136452-A1 (HK)
Title: Radio communication system and mobile station device
Inventor: YAMADA SHOHEI
IPC: H04W/
Filed: 2010-03-24
Abstract: A mobile station in synchronous status randomly selects a preamble ID and sends it to the base station to perform random access. The base station sends to the mobile station device a random access response in the PDSCH corresponding to a Random Access- Radio Temporary Identity (RA-RNTI) in the PDCCH. Within the same subframe, the base station sends in the PDCCH the C-RNTI of the mobile station and assigns resources on the PDSCH for mobile data.